Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-066519
Filing Date
2026-05-27
Accepted
2026-05-27 06:04:42
Documents
97
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grdx-20260331x10q.htm   iXBRL 10-Q 1642356
2 EX-31.1 grdx-20260331xex31d1.htm EX-31.1 12423
3 EX-31.2 grdx-20260331xex31d2.htm EX-31.2 12433
4 EX-32.1 grdx-20260331xex32d1.htm EX-32.1 7995
  Complete submission text file 0001104659-26-066519.txt   9142754

Data Files

Seq Description Document Type Size
5 EX-101.SCH grdx-20260331.xsd EX-101.SCH 73429
6 EX-101.CAL grdx-20260331_cal.xml EX-101.CAL 66910
7 EX-101.DEF grdx-20260331_def.xml EX-101.DEF 335593
8 EX-101.LAB grdx-20260331_lab.xml EX-101.LAB 630054
9 EX-101.PRE grdx-20260331_pre.xml EX-101.PRE 528067
101 EXTRACTED XBRL INSTANCE DOCUMENT grdx-20260331x10q_htm.xml XML 1476663
Mailing Address 433 PLAZA REAL SUITE 275 BOCA RATON FL
Business Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 561-589-7020
GridAI Technologies Corp. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37853 | Film No.: 261022056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)